tb 500 and bpc 157 nasal spray oral vs vs injection bpc-157 Peptide: Injectable, Oral, Delivery Methods Compared — Which Is Right for Your Goal? oral – BPC-157 Nasal vs. Injections – bpc-157 intranasal study Nasal Spray

Another TKI, gefitinib (ZD1839, Iressa), which targets the epidermal growth factor receptor (EGFR), has been shown to restrict M.tb replication in both macrophages as well as in the lungs of M.tb -infected mice by promoting the host autophagy pathway through the inhibition of the p38 MAPK signaling pathway activated by EGFR [10]

Other small molecule inhibitors have also been reported, including those derived from amino adenosine and other nicotinamide-related compounds 206,207,208

How to enter a bacterium: bacterial porins and the permeation of antibiotics

Stress/cell death pathways, neuroinflammation and neuropathic pain